Delivery Order SPE2DB20D1109-SPE2DB25FP53L
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,524.09 delivery order on July 29, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count). This is a firm fixed-price, competitively awarded contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 30, 2025. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,132.01 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This firm fixed price, competitively awarded contract represents a non-set-aside procurement and is scheduled for completion by September 29, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $36,826.86 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $10,547.87 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, due for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $20,357.51 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,041.98 delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed price, non-set-aside contract with a completion date of June 13, 2025, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on September 24, 2025, with a ceiling value of $26,026.55. This is a firm fixed-price delivery order with no set-aside designation, executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $11,596.65 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-unit package). This firm fixed-price, non-set-aside contract is set for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $19,371.24 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). The award is non-competitive and utilizes firm fixed-price pricing, with an ultimate completion date of August 18, 2025. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical...
- The Defense Logistics Agency awarded a $31,540.49 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP53LDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) at a ceiling value of $63,083.25 under a firm fixed-price arrangement. This is a competitively awarded, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 8, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999 through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and Defense Health Agency. The company maintains an extensive portfolio of federal contract awards covering diverse pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular order for Trelegy Ellipta, a combination respiratory maintenance medication, reflects the company's ongoing role in supplying essential medications to military and veteran healthcare systems through the DLA's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $63.1k | 8/7/25 |